CN104644665A - Medicine for treating arthritis - Google Patents
Medicine for treating arthritis Download PDFInfo
- Publication number
- CN104644665A CN104644665A CN201410292150.4A CN201410292150A CN104644665A CN 104644665 A CN104644665 A CN 104644665A CN 201410292150 A CN201410292150 A CN 201410292150A CN 104644665 A CN104644665 A CN 104644665A
- Authority
- CN
- China
- Prior art keywords
- medicine
- arthritis
- treatment
- nimesulide
- treating arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a medicine for treating arthritis and belongs to the technical field of medicines. The medicine is prepared from the following raw materials in percentage by weight: 55-60% of chondroitin sulfate, 15-20% of nimesulide and 20-25% sodium loxoprofen. The medicine disclosed by the invention has a significant effect of treating arthritis.
Description
Technical field
The present invention relates to field of medical technology, especially a kind of medicine for the treatment of of arthritis.
Background technology
Arthritis is the arthritis pathological changes caused by inflammation, infection, wound or other factors, belongs to rheumatism subject disease, commonly osteoarthritis and rheumatoid arthritis.Osteoarthritis is a kind of common progressive degeneration disease, and Major Members is old people.The cost that the actuarial prediction whole world in 2020 is used for the treatment of osteoarthritis is approximately 15,500,000,000 dollars.The patient with rheumatoid arthritis major part age between 35 years old ~ 50 years old, because of its cause of disease with heredity, infects, environment, immunity have complex relationship, the clinical method that there is no thoroughly is effected a radical cure, and can only pass through Drug therapy symptom management, maintenance function of joint.
Summary of the invention
The object of this invention is to provide a kind of medicine for the treatment of of arthritis, adopt this Drug therapy arthritis, evident in efficacy.
In order to solve the problem, the technical solution used in the present invention is: a kind of medicine for the treatment of of arthritis, is made up of the raw material of following percentage by weight: chondroitin sulfate 55% ~ 60%, nimesulide 15% ~ 20%, loxoprofen sodium 20% ~ 25%.
The preparation method of the medicine of described treatment coronary heart disease is: take each raw material according to percentage by weight, pulverizes, and crosses 300 order molecular sieves, conventionally makes oral tablet.
Owing to have employed technique scheme, the present invention compared with prior art has following beneficial effect:
Medicine of the present invention contains chondroitin sulfate, and nimesulide and loxoprofen sodium, take this medicine according to the course for the treatment of, can not only have good preventive effect to arthritis, and therapeutic effect is remarkable, and curative effect is fast, and short treating period, curative effect is more stable, not easily recurs.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1
Respectively by chondroitin sulfate, nimesulide, loxoprofen sodium is pulverized, and cross 300 order molecular sieves, get 550 grams of chondroitin sulfate powder, 200 grams of nimesulide powder, 250 Clotho ibuprofen sodium powder, mix homogeneously, makes oral tablet, and every tablet is 50 milligrams.
Embodiment 2
Respectively by chondroitin sulfate, nimesulide, loxoprofen sodium is pulverized, and cross 300 order molecular sieves, get 600 grams of chondroitin sulfate powder, 150 grams of nimesulide powder, 250 Clotho ibuprofen sodium powder, mix homogeneously, makes oral tablet, and every tablet is 50 milligrams.
Embodiment 3
Respectively by chondroitin sulfate, nimesulide, loxoprofen sodium is pulverized, and cross 300 order molecular sieves, get 600 grams of chondroitin sulfate powder, 200 grams of nimesulide powder, 200 Clotho ibuprofen sodium powder, mix homogeneously, makes oral tablet, and every tablet is 50 milligrams.
Clinical trial:
1, clinical data: the present invention accepts arthritic 268 example for medical treatment, wherein, man 147 example, female 121 example, patient age is 35 years old ~ 60 years old, the course of disease 3 ~ 10 years.
2, Therapeutic Method: patient takes medicine prepared by embodiment, every day three times, each two panels, oral meal, 10 days courses for the treatment of, the treatment phase is 30 days.
3, efficacy determination:
Effective: after adopting this Drug therapy, joint can be freely movable, and arthralgia, numb phenomenon disappear.
Effective: after adopting this Drug therapy, arthralgia, numb situation are alleviated to some extent.
Invalid: after adopting this Drug therapy, health does not take a turn for the better, and medicine is not had an effect.
4, therapeutic effect: through the observation treatment of 30 days, in 268 routine patients, the remarkable patient of curative effect is 236 examples, and effective patient is 16 examples, and the patient that fails to respond to any medical treatment is 16 examples.
In sum, this curative effect of medication is remarkable, and total effective rate reaches 94%.This medicine has significant curative effect to arthritis, and patient is generally after taking medicine one week, and joint numbness, the symptom swollen and ache obviously alleviate or disappear.
Claims (1)
1. a medicine for treatment of arthritis, is characterized in that, is made up of the raw material of following percentage by weight: chondroitin sulfate 55% ~ 60%, nimesulide 15% ~ 20%, loxoprofen sodium 20% ~ 25%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410292150.4A CN104644665A (en) | 2014-06-26 | 2014-06-26 | Medicine for treating arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410292150.4A CN104644665A (en) | 2014-06-26 | 2014-06-26 | Medicine for treating arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104644665A true CN104644665A (en) | 2015-05-27 |
Family
ID=53236635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410292150.4A Pending CN104644665A (en) | 2014-06-26 | 2014-06-26 | Medicine for treating arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104644665A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1575182A (en) * | 2001-08-14 | 2005-02-02 | 法马西亚公司 | Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| JP2008195705A (en) * | 2007-01-15 | 2008-08-28 | Daiichi Sankyo Healthcare Co Ltd | Loxoprofen-containing oral composition |
| CN101259139A (en) * | 2008-03-13 | 2008-09-10 | 北京阜康仁生物制药科技有限公司 | Pharmaceutical composition for anti-inflammation ease-pain |
| CN101342147A (en) * | 2008-08-28 | 2009-01-14 | 复旦大学 | Loxoprofen sodium framework tablet |
| CN102670531A (en) * | 2012-04-19 | 2012-09-19 | 迪沙药业集团有限公司 | Loxoprofen sodium composition |
| CN103751767A (en) * | 2013-12-15 | 2014-04-30 | 青岛东海药业有限公司 | Medicament composition and application thereof |
-
2014
- 2014-06-26 CN CN201410292150.4A patent/CN104644665A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1575182A (en) * | 2001-08-14 | 2005-02-02 | 法马西亚公司 | Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| JP2008195705A (en) * | 2007-01-15 | 2008-08-28 | Daiichi Sankyo Healthcare Co Ltd | Loxoprofen-containing oral composition |
| CN101259139A (en) * | 2008-03-13 | 2008-09-10 | 北京阜康仁生物制药科技有限公司 | Pharmaceutical composition for anti-inflammation ease-pain |
| CN101342147A (en) * | 2008-08-28 | 2009-01-14 | 复旦大学 | Loxoprofen sodium framework tablet |
| CN102670531A (en) * | 2012-04-19 | 2012-09-19 | 迪沙药业集团有限公司 | Loxoprofen sodium composition |
| CN103751767A (en) * | 2013-12-15 | 2014-04-30 | 青岛东海药业有限公司 | Medicament composition and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yue et al. | Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study | |
| CN104188999A (en) | Composition capable of increasing bone density and improving functions of skeletons and joints and preparation method thereof | |
| CN103768123A (en) | Traditional Chinese medicine composition and preparation method thereof | |
| Lu et al. | Osteoporosis, importance for early diagnosis and treatment | |
| CN104644665A (en) | Medicine for treating arthritis | |
| CN1843443A (en) | Rheumatoid disease treating plaster | |
| CN102671076B (en) | Medicament for treating gout | |
| CN104644666A (en) | Medicine for treating coronary heart disease | |
| CN102961520B (en) | Pharmaceutical composition for treating arthritis and method for preparing pharmaceutical composition for treating arthritis | |
| CN102274308B (en) | Chinese herbal medicine capsule for treating male infertility | |
| CN106166287A (en) | A kind of Chinese medicine for treating skin pruritus | |
| CN102743574B (en) | Compound Chinese herbal medicine capsule for treating and killing mycobacterium tuberculosis and preparation method | |
| CN106729427B (en) | External traditional Chinese medicine composition for treating wind-damp-cold arthralgia, using method and application thereof | |
| CN102716129B (en) | Application of ligustrazine to medicines for adjuvant therapy of rheumatoid diseases | |
| CN1539448A (en) | Medicine for treating rheumatic and rheumatoid arthritis | |
| Kumari et al. | ADRs (Adverse Drug Reactions) related to ayurvedic medicine used in COVID-19 | |
| Voznyak et al. | The rationality of the drugs prescriptions for patients with coronary heart disease in medical institutions of Ukraine | |
| CN103877433A (en) | Chinese medicinal composition for treating arthritis and preparation method thereof | |
| Sangeetha et al. | SIDDHA TREATMENT OF PALMOPLANTAR PSORIASIS-A CASE STUDY | |
| CN104069356A (en) | Traditional Chinese medicine for treating pneumorrhagia | |
| CN104815308A (en) | Traditional Chinese medicine formula for treating cardiovascular and cerebrovascular diseases | |
| CN103735931B (en) | A kind of Chinese medicine preparation for the treatment of chronic cholecystitis | |
| CN106176866A (en) | Local injection treats the medicine of chronic neck, shoulder, waist and leg arthralgia | |
| CN101507785A (en) | Ointment for treating psoriasis | |
| CN102266430A (en) | Drug for treating mouth and tongue sores and oral ulcers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150527 |